PPG INDUSTRIES INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that PPG INDUSTRIES INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Sep 30, 2017 | $3.78B | Jun 28, 2018 |
| FY2017 | Jun 30, 2017 | $3.80B | Jun 28, 2018 |
| FY2017 | Mar 31, 2017 | $3.49B | Jun 28, 2018 |
| FY2017 | Sep 30, 2016 | $3.66B | Jun 28, 2018 |
| FY2017 | Jun 30, 2016 | $3.78B | Jun 28, 2018 |
| FY2017 | Mar 31, 2016 | $3.41B | Jun 28, 2018 |
| FY2013 | Dec 31, 2013 | $15.11B | Feb 20, 2014 |
| FY2013 | Dec 31, 2012 | $13.51B | Feb 20, 2014 |
| FY2013 | Dec 31, 2011 | $13.15B | Feb 20, 2014 |
| FY2012 | Dec 31, 2010 | $13.42B | Feb 21, 2013 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $15.88B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $15.85B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $16.24B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $15.61B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $16.80B | Feb 15, 2024 |
| FY2020 | Dec 31, 2020 | $3.76B | Feb 18, 2021 |
| FY2020 | Sep 30, 2020 | $3.69B | Feb 18, 2021 |
| FY2020 | Jun 30, 2020 | $3.02B | Feb 18, 2021 |
| FY2020 | Mar 31, 2020 | $3.38B | Feb 18, 2021 |
| FY2020 | Dec 31, 2019 | $3.67B | Feb 18, 2021 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $3.68B | Jun 28, 2018 |
| FY2017 | Sep 30, 2017 | $3.78B | Jun 28, 2018 |
| FY2017 | Jun 30, 2017 | $3.80B | Jun 28, 2018 |
| FY2017 | Mar 31, 2017 | $3.49B | Jun 28, 2018 |
| FY2017 | Dec 31, 2016 | $3.42B | Jun 28, 2018 |
| FY2017 | Sep 30, 2016 | $3.66B | Jun 28, 2018 |
| FY2017 | Jun 30, 2016 | $3.78B | Jun 28, 2018 |
| FY2017 | Mar 31, 2016 | $3.41B | Jun 28, 2018 |
| FY2016 | Dec 31, 2015 | $3.55B | Feb 16, 2017 |
| FY2016 | Sep 30, 2015 | $3.73B | Feb 16, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.58B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $1.12B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $1.27B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $1.03B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $1.44B | Feb 15, 2024 |
| FY2020 | Dec 31, 2020 | $272.00M | Feb 18, 2021 |
| FY2020 | Sep 30, 2020 | $442.00M | Feb 18, 2021 |
| FY2020 | Jun 30, 2020 | $102.00M | Feb 18, 2021 |
| FY2020 | Mar 31, 2020 | $243.00M | Feb 18, 2021 |
| FY2020 | Dec 31, 2019 | $292.00M | Feb 18, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $2.68B | Feb 15, 2024 |
| FY2023 | Dec 31, 2022 | $2.04B | Feb 15, 2024 |
| FY2023 | Dec 31, 2021 | $2.17B | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $2.11B | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $2.27B | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $2.12B | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $2.29B | Feb 20, 2020 |
| FY2017 | Sep 30, 2017 | $589.00M | Jun 28, 2018 |
| FY2017 | Jun 30, 2017 | $673.00M | Jun 28, 2018 |
| FY2017 | Mar 31, 2017 | $557.00M | Jun 28, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $446.00M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $447.00M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $446.00M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $457.00M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $463.00M | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $401.00M | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $456.00M | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $464.00M | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $472.00M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $473.00M | Feb 21, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.44B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $3.39B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $3.40B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $3.04B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $3.78B | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $3.39B | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $3.60B | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $3.57B | Feb 18, 2021 |
| FY2017 | Dec 31, 2017 | $908.00M | Jun 28, 2018 |
| FY2017 | Sep 30, 2017 | $902.00M | Jun 28, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.94B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $1.42B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $2.41B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $963.00M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $1.56B | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $2.13B | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $2.08B | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $1.47B | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $1.57B | Feb 20, 2020 |
| FY2017 | Sep 30, 2017 | $1.03B | Jun 28, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $778.00M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $721.00M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $516.00M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $486.00M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $371.00M | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $304.00M | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $413.00M | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $411.00M | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $360.00M | Feb 20, 2020 |
| FY2017 | Sep 30, 2017 | $207.00M | Jun 28, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $22.10B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $19.43B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $21.65B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $20.74B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $21.35B | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $19.56B | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $17.71B | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $16.02B | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $16.54B | Feb 20, 2020 |
| FY2017 | Sep 30, 2017 | $17.62B | Jun 28, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.00B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $12.47B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $13.62B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $14.04B | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $14.94B | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | $13.74B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $12.31B | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $11.28B | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $10.87B | Feb 21, 2019 |
| FY2017 | Sep 30, 2017 | $11.61B | Jun 28, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.94B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $6.79B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $7.83B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $6.59B | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $6.29B | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | $5.69B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $5.28B | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $4.63B | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $5.56B | Feb 21, 2019 |
| FY2017 | Sep 30, 2017 | $5.90B | Jun 28, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.15B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $5.69B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $6.12B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $5.99B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $6.25B | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $5.10B | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $4.47B | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $4.07B | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $3.94B | Feb 20, 2020 |
| FY2017 | Sep 30, 2017 | $3.88B | Jun 28, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $22.94B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $21.99B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $21.50B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $20.83B | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $20.37B | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | $19.47B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $18.91B | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $18.13B | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $17.14B | Feb 21, 2019 |
| FY2017 | Sep 30, 2017 | $17.10B | Jun 28, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.16B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $1.27B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $1.49B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $1.10B | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $1.01B | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | $1.83B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $1.22B | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $902.00M | Feb 20, 2020 |
| FY2019 | Dec 31, 2017 | $1.44B | Feb 20, 2020 |
| FY2017 | Sep 30, 2017 | $2.29B | Jun 28, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.30B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $5.80B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $6.04B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $6.80B | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $6.57B | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | $5.33B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $5.03B | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $5.00B | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $4.12B | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $4.30B | Jun 28, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 6 | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 4 | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | 5 | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | 4 | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | 6 | Feb 15, 2024 |
| FY2020 | Dec 31, 2020 | 1 | Feb 18, 2021 |
| FY2020 | Sep 30, 2020 | 1 | Feb 18, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 18, 2021 |
| FY2020 | Mar 31, 2020 | 1 | Feb 18, 2021 |
| FY2020 | Dec 31, 2019 | 1 | Feb 18, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 6 | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 4 | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | 5 | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | 4 | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | 6 | Feb 15, 2024 |
| FY2020 | Dec 31, 2020 | 1 | Feb 18, 2021 |
| FY2020 | Sep 30, 2020 | 1 | Feb 18, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 18, 2021 |
| FY2020 | Mar 31, 2020 | 1 | Feb 18, 2021 |
| FY2020 | Dec 31, 2019 | 1 | Feb 18, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 223.43M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 229.93M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | 235.21M | Feb 19, 2026 |
| FY2025 | Dec 31, 2022 | 235.07M | Feb 19, 2026 |
| FY2024 | Dec 31, 2021 | 235.91M | Feb 20, 2025 |
| FY2023 | Dec 31, 2020 | 236.69M | Feb 15, 2024 |
| FY2022 | Dec 31, 2019 | 235.68M | Feb 16, 2023 |
| FY2021 | Dec 31, 2018 | 235.86M | Feb 17, 2022 |
| FY2020 | Dec 31, 2017 | 251.17M | Feb 18, 2021 |
| FY2019 | Dec 31, 2016 | 257.33M | Feb 20, 2020 |